...
首页> 外文期刊>Journal of Molecular Liquids >Characterization and application of mixed micellar assemblies of PEO-PPO star block copolymers for solubilization of hydrophobic anticancer drug and in vitro release
【24h】

Characterization and application of mixed micellar assemblies of PEO-PPO star block copolymers for solubilization of hydrophobic anticancer drug and in vitro release

机译:PEO-PPO星嵌段共聚物混合胶束组装的特征与应用,用于疏水性抗癌药物和体外释放的溶解

获取原文
获取原文并翻译 | 示例
           

摘要

Over the past few decades, polymeric micelles have attracted enormous attention due to their beneficial properties such as (i) core-shell structure, capable to accommodate hydrophobic drugs, boosting the overall solubility in aqueous medium; (ii) appropriate size which favors accumulation within the tumor, displaying improved permeability and retention (EPR) elfect and (iii) unimers that tune the activity of efflux pumps engaged in multidrug resistance (MDR). Taking this into consideration, the present study aims the optimization and application of mixed copolymeric system of polyethylene oxide-polypropylene oxide (PEO-PPO) star block copolymers, Tetronics (R) 901 and 904 (hereafter written as T901 and1904), with almost same molecular weight of PPO blocks but distinct PEO block lengths, for the solubilization and in vitro release of hydrophobic anticancer drug, curcumin (CN). The copolymer T901 being incorporated with a long PPO block (10% PEO, M. Wt. 4700) is highly unstable and has poor water solubility at ambient temperature. Thus, undergoes phase separation at temperatures below 25 degrees C. Tetronic (R) T904 (40% PEO, M. Wt. 6700) with relatively longer PEO blocks forms stable core-shell micelles (hydrodynamic diameter, D-h similar to 12.0 nm and aggregation number, N-agg similar to 24) in water. The inclusion of copolymer T901 in the micellar system of T904 is mutually beneficial for both the copolymers as the insertion of T901 in 1904 extends its PPO core and consequently improves its drug solubilizing capacity. On the other hand, the solubility of T901, which otherwise remains insoluble in water (at ambient temperature) is increased. Hence, the assemblies so formed are more efficient for drug delivery and improve the carrier properties of both the copolymers. The solubility and release profiles of drug was also checked in the presence of commonly used pharmaceutical excipients viz sodium chloride (NaCl) and glucose in isotonic conditions and it was witnessed that the presence of both the excipients promoted micellization and augmented the solubilization capacity of the mixed assemblies many folds. The in-vitro release profiles suggested release of drug through diffusion from the mixed assemblies. (C) 2020 Elsevier B.V. All rights reserved.
机译:在过去的几十年中,聚合物胶束已经引起极大的关注,因为它们有益的性质,例如(i)芯 - 壳结构,可容纳疏水性药物,升压在水性介质中的总溶解度; (ⅱ)合适的尺寸,这有利于在肿瘤内积聚,显示改善的渗透性和保留(EPR)elfect和(iii)单聚体即调流出的活性泵从事多药耐药性(MDR)。考虑到这一点,本研究的目的是优化和聚环氧乙烷 - 聚环氧丙烷(PEO-PPO)星嵌段共聚物,TETRONICS(R)901和904(以下写为T901 and1904)的混合共聚体系的应用,具有几乎相同的分子量PPO嵌段但不同的PEO嵌段长度的,用于增溶和体外疏水抗癌药物,姜黄素(CN)的释放。该共聚物T901被掺入具有长PPO嵌段(10%PEO,M.重量4700)是高度不稳定的并且具有在环境温度下的水的溶解性差。因此,发生相分离,在与相对较长的PEO嵌段的形式温度低于25摄氏度的Tetronic(R)T904(40%PEO,M.重量6700)稳定的核 - 壳胶束(流体动力学直径,DH类似12.0纳米和聚集数,在水中的N- AGG类似于24)。共聚物T901的T904中的胶束体系包含对于两个共聚物作为T901的在1904插入延伸其PPO芯,并因此提高了它的药物的溶解能力互利。在另一方面,T901,的否则保持在不溶于水的(在环境温度)中的溶解度增加。因此,如此形成的组件是用于药物递送更有效并改善共聚物的载体性质。药物的溶解度和释放曲线还检查在常用的药用赋形剂即氯化钠(NaCl)和葡萄糖在等渗条件的存在和它被目击的是,赋形剂的存在促进胶束和增强混合的溶解能力组件很多倍。的体外释放曲线通过从所述混合组件扩散建议药物的释放。 (c)2020 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号